Significant impact of 5α-reductase type 2 polymorphisms on sperm concentration and motility

International Journal of Andrology

Volumn 29, Issue 3, 2006, Pages 414-420

  Elzanaty, S ^a   Giwercman, Y L ^a   Giwercman, A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Polymorphism; Semen parameter; SRD5A2 gene

Indexed keywords

ALPHA GLUCOSIDASE; ANDROGEN; ANDROSTANOLONE; BIOCHEMICAL MARKER; FRUCTOSE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; ZINC; SEX HORMONE; STEROID 5ALPHA REDUCTASE;

ACCESSORY SEX GLAND; ALLELE; ARTICLE; COMPUTER ANALYSIS; CONCENTRATION RESPONSE; DNA DETERMINATION; ENZYME MECHANISM; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MILITARY MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEMEN ANALYSIS; SPERMATOGENESIS; SPERMATOZOON MOTILITY; SRD5A2 GENE; SWEDEN; ADOLESCENT; BLOOD; EPIDIDYMIS; GENETICS; MALE; PHYSIOLOGY; SEMINAL VESICLE; SOLDIER; SPERMATOZOON; SPERMATOZOON COUNT;

ADOLESCENT; EPIDIDYMIS; GONADAL STEROID HORMONES; HUMANS; MALE; MILITARY PERSONNEL; POLYMORPHISM, GENETIC; SEMINAL VESICLES; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA; SWEDEN; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 33646682640     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2005.00625.x     Document Type: Article

References (31)

1. Andersen A. G. Jensen T. K. Carlsen E. Jørgensen N. Andersson A.-M. Krarup T. Keiding N. Skakkebaek N. E. 2000 High frequency of sub-optimal semen quality among young men of the general Danish population Human Reproduction 15 366 372
2. Anderson R. A. Wallace A. M. Wu F. C. 1996 Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone Journal of Clinical Endocrinology and Metabolism 81 902 908
3. Cicek M. S. Conti D. V. Curran A. Neville P. J. Paris P. L. Casey G. Witte J. S. 2004 Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR Prostate 59 69 76
4. Eicheler W. Tuohimaa P. Vilja P. Adermann K. Forssmann W. G. Aumuller G. 1994 Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues Journal of Histochemistry and Cytochemistry 42 667 675
5. Elzanaty S. Richthoff J. Malm J. Giwercman A. 2002 The impact of the epididymal and accessory sex glands function on sperm motility Human Reproduction 17 2904 2911
6. Elzanaty S. Malm J. Giwercman A. 2005 Duration of sexual abstinence: epididymal and accessory sex gland secretions and their relationship to sperm motility Human Reproduction 20 221 225
7. Groome N. P. Illingworth P. J. O'Brien M. Pai R. Rodger F. E. Mather J. P. McNeilly A. S. 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle Journal of Clinical Endocrinology and Metabolism 81 1401 1405
8. Henderson N. A. Robaire B. 2005 Effects of PNU157706, a dual 5alpha-reductase inhibitor, on rat epididymal sperm maturation and fertility Biology of Reproduction 72 436 443
9. Hines R. S. Tho S. P. Behzadian M. A. McDonough P. G. 1999 Steroid 5α-reductase 2 gene melting polymorphisms in male subjects with azoospermia or oligospermia American Journal of Obstetrics and Gynaecology 180 1394 1398
10. Hsing A. W. Chen C. Chokkalingam A. P. Gao Y. T. Dightman D. A. Nguyen H. T. et al. 2001 Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study Cancer Epidemiology, Biomarkers & Prevention 10 1077 1082
11. Katz M. D. Kligman I. Cai L. Q. Zhu Y. S. Fratianni C. M. Zervoudakis I. Rosenwaks Z. Imperato-McGinley J. 1997 Paternity by intrauterine insemination with sperm from a man with 5alpha-reductase-2 deficiency New England Journal of Medicine 336 994 997
12. Latil A. G. Azzouzi R. Cancel G. S. Guillaume E. C. Cochan-Priollet B. Berthon P. L. Cussenot O. 2001 Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways Cancer 92 1130 1137
13. Lundin K. B. Giwercman A. Richthoff J. Abrahamsson P.-A. Giwercman Y. L. 2003 No association between mutations in the human androgen receptor GGN repeat and inter-sex conditions Molecular Human Reproduction 9 375 379
14. Makridakis N. Ross R. K. Pike M. C. 1997 A prevalent missense substitution that modulates activity of prostatic steroid 5 alpha-reductase Cancer Research 57 1020 1022
15. Makridakis N. M. Ross R. K. Pike M. C. Crocitto L. E. Kolonel L. N. Pearce D. 1999 Association of missense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA Lancet 354 975 978
16. Makridakis N. M. di Salle E. Reichardt J. K. 2000 Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II Pharmacogenetics 10 407 413
17. Matthiesson K. L. Amory J. K. Berger R. Ugoni A. McLachlan R. I. Bremner W. J. 2005 Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist Journal of Clinical Endocrinology and Metabolism 90 91 97
18. Mononen N. Ikonen T. Syrjakoski K. Matikainen M. Schleutker J. Tammela T. L. Koivisto P. A. Kallioniemi O. P. 2001 A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland British Journal of Cancer 84 1344 1347
19. Nordenskjold A. Ivarsson S. A. 1998 Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family Journal of Clinical Endocrinology and Metabolism 83 3236 3238
20. Ntais C. Polycarpou A. Ioannidis J. P. 2003 SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis Cancer epidemiology, biomarkers & prevention 12 618 624
21. Overstreet J. W. Fuh V. L. Gould J. Howards S. S. Lieber M. M. Hellstrom W. et al. 1999 Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men Journal of Urology 162 1295 1300
22. Payne A. H. Kawano A. Jaffe R. B. 1973 Formation of dihydrotestosterone and other 5 alpha-reduced metabolites by isolated seminiferous tubules and suspension of interstitial cells in a human testis Journal of Clinical Endocrinology and Metabolism 37 448 453
23. Richthoff J. Rylander L. Hagmar L. Malm J. Giwercman A. 2002 Higher sperm counts in Southern Sweden compared with Denmark Human Reproduction 17 2468 2473
24. Saez J. M. 1994 Leydig cells: endocrine, paracrine and autocrine regulation Endocrine reviews 15 574 626
25. Salam M. T. Ursin G. Skinner E. C. Dessissa T. Reichardt J. K. 2005 Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer Urologic Oncology 23 246 253
26. Soderstrom T. Wadelius M. Andersson S. O. Johansson J. E. Johansson S. Granath F. Rane A. 2002 5alpha-reductase 2 polymorphisms as risk factors in prostate cancer Pharmacogenetics 12 307 312
27. Sultan C. Lumbroso S. Paris F. Jeandel C. Terouanne B. Belon C. et al. 2002 Disorders of androgen action Seminars in Reproductive Medicine 20 217 228
28. Vermeulen A. Verdonck L. Kaufman J. M. 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum Journal of Clinical Endocrinology and Metabolism 84 3666 3672
29. World Health Organization 1999 WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction 4th edn The Press Syndicate of the University of Cambridge Cambridge, UK
30. World Health organization task force on methods of the regulation of male fertility 1990 Contraceptive efficacy of testosterone-induced azoospermia in normal men Lancet 336 955 959
31. World Health organization task force on methods of the regulation of male fertility 1996 Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men Fertility and Sterility 63 125 133